# Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women

> **NCT06952712** · PHASE3 · NOT_YET_RECRUITING · sponsor: **FANG HE** · enrollment: 1300 (estimated)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Aspirin 100mg
- **DRUG:** Aspirin 150mg

## Key facts

- **NCT ID:** NCT06952712
- **Lead sponsor:** FANG HE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-07
- **Primary completion:** 2028-05-06
- **Final completion:** 2028-05-06
- **Target enrollment:** 1300 (ESTIMATED)
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06952712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06952712, "Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06952712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*